- Exchange: NYSE MKT LLC
- Sector: Health Care
- Industry: Health Care Facilities/Srvcs
- Sub-Industry: Health Care Services
Snapshot for Neostem Inc (NBS)
| Open: | 0.5399 | Day's Range: | 0.5220 - 0.5399 | Volume: | 750,071 |
|---|---|---|---|---|---|
| Previous Close: | 0.5330 | 52wk Range: | 0.4100 - 0.8435 | 1-Yr Rtn: | +20.58% |
Key Statistics for NBS
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -0.1400 |
| Est. EPS (USD) (12/2013) | -0.1600 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 104.46 |
| Shares Outstanding (M) | 193.80 |
| 30 Day Average Volume | 632,913 |
| Price/Book (mrq) | 3.1191 |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/14/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for NBS
Company Profile & Key Executives for NBS
NeoStem, Inc. develops and manufactures cell therapies. The Company through its subsidiaries offers contract manufacturing services and is developing a cell therapy for the treatment of cardiovascular disease.
| Robin L SmithChairman/CEO | Andrew L PecoraChief Medical Officer |
| Larry A MayVP/CFO | Joseph Talamo "Joe"VP/Chief Acctg Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
NBS News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page